A CASE STUDY ON THE AYURVEDIC MANAGEMENT OF HASHIMOTO'S THYROIDITIS FOLLOWING COVID-19

Read full text
Authors: Dr. Amirtha Lakshmi T.1*, Dr. Pradeep Kumar Moharana2, Dr. Suvendu Rout3, Dr. Vijayarajaa P.4
Cited by: 0

Abstract

Introduction: Hashimoto's Thyroiditis is an emerging post- COVID complication, conventionally managed with T4 replacement. However, this approach focuses on symptoms rather than the root cause. This case study details a holistic Ayurvedic approach using Hetu Parivarjana, Shodhana, and Rasayana to manage the condition. Methods: A 24-year-old female with post-COVID Hashimoto's presented with tiredness and weight gain associated with occasional dizziness and mood swings. The Agnimandya and Rasavaha Srotas Dushti were addressed with Deepana, Pachana, Snehapana, Vamana and Rasayana. The therapeutic regimen aims to correct the Kapha, Pitta Dosha imbalance. Results: Post-Ayurvedic intervention, the patient’s TSH levels decreased significantly, and her clinical symptoms, including fatigue and weight gain, improved markedly. The Shodhana, Shamana and Rasayana therapies restored her Agni and Srotas, leading to profound Dhatu Pushti. Discussion & Conclusion: The success of this case highlights the efficacy of the Ayurvedic approach. Deepana- Pachana with Chitrakadi Vati helped in rekindling the Agni, Aarohana Matra Snehapana with Varanadi Ghrita facilitated the movement of vitiated Dushya from Sakha to Koshta which was eliminated out by Vamana Karma and helped clearing the Srotas. The Shamana Aushadhi such as Varanadi Kashaya, Kanchanara Guggulu were given along with Rasayana Churna for its Balya and Amanashana Karma, which served as an immunomodulator, addressing the autoimmune response at its source. This case demonstrates that Ayurveda offers a promising alternative to conventional, symptom-based treatments for post-COVID Hashimoto's.

Fields of Study & Subjects

Traditional Chinese Medicine Studies Thyroid Disorders and Treatments Phytochemicals and Medicinal Plants

Publication details

Journal / source
World Journal of Pharmaceutical Research
Publication date
1 March 2026
Language
EN